254 related articles for article (PubMed ID: 35056060)
21. Drug targeting to the brain.
Pardridge WM
Pharm Res; 2007 Sep; 24(9):1733-44. PubMed ID: 17554607
[TBL] [Abstract][Full Text] [Related]
22. Biologic TNFα-inhibitors that cross the human blood-brain barrier.
Pardridge WM
Bioeng Bugs; 2010; 1(4):231-4. PubMed ID: 21327054
[TBL] [Abstract][Full Text] [Related]
23. Disaggregation of amyloid plaque in brain of Alzheimer's disease transgenic mice with daily subcutaneous administration of a tetravalent bispecific antibody that targets the transferrin receptor and the Abeta amyloid peptide.
Sumbria RK; Hui EK; Lu JZ; Boado RJ; Pardridge WM
Mol Pharm; 2013 Sep; 10(9):3507-13. PubMed ID: 23924247
[TBL] [Abstract][Full Text] [Related]
24. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse.
Lee HJ; Engelhardt B; Lesley J; Bickel U; Pardridge WM
J Pharmacol Exp Ther; 2000 Mar; 292(3):1048-52. PubMed ID: 10688622
[TBL] [Abstract][Full Text] [Related]
25. Blood-brain barrier molecular trojan horse enables imaging of brain uptake of radioiodinated recombinant protein in the rhesus monkey.
Boado RJ; Hui EK; Lu JZ; Sumbria RK; Pardridge WM
Bioconjug Chem; 2013 Oct; 24(10):1741-9. PubMed ID: 24059813
[TBL] [Abstract][Full Text] [Related]
26. Selective targeting of a TNFR decoy receptor pharmaceutical to the primate brain as a receptor-specific IgG fusion protein.
Boado RJ; Hui EK; Lu JZ; Zhou QH; Pardridge WM
J Biotechnol; 2010 Mar; 146(1-2):84-91. PubMed ID: 20100527
[TBL] [Abstract][Full Text] [Related]
27. Study of the transcytosis of an anti-transferrin receptor antibody with a Fab' cargo across the blood-brain barrier in mice.
Manich G; Cabezón I; del Valle J; Duran-Vilaregut J; Camins A; Pallàs M; Pelegrí C; Vilaplana J
Eur J Pharm Sci; 2013 Jul; 49(4):556-64. PubMed ID: 23748097
[TBL] [Abstract][Full Text] [Related]
28. Plasma Pharmacokinetics of High-Affinity Transferrin Receptor Antibody-Erythropoietin Fusion Protein is a Function of Effector Attenuation in Mice.
Sun J; Boado RJ; Pardridge WM; Sumbria RK
Mol Pharm; 2019 Aug; 16(8):3534-3543. PubMed ID: 31199881
[TBL] [Abstract][Full Text] [Related]
29. Brain iron homeostasis.
Moos T
Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
[TBL] [Abstract][Full Text] [Related]
30. Brain-penetrating tumor necrosis factor decoy receptor in the mouse.
Zhou QH; Boado RJ; Hui EK; Lu JZ; Pardridge WM
Drug Metab Dispos; 2011 Jan; 39(1):71-6. PubMed ID: 20884844
[TBL] [Abstract][Full Text] [Related]
31. Treatment of Parkinson's disease with biologics that penetrate the blood-brain barrier via receptor-mediated transport.
Pardridge WM
Front Aging Neurosci; 2023; 15():1276376. PubMed ID: 38035276
[TBL] [Abstract][Full Text] [Related]
32. Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood-brain barrier in vitro is dependent on its binding affinity.
Haqqani AS; Thom G; Burrell M; Delaney CE; Brunette E; Baumann E; Sodja C; Jezierski A; Webster C; Stanimirovic DB
J Neurochem; 2018 Sep; 146(6):735-752. PubMed ID: 29877588
[TBL] [Abstract][Full Text] [Related]
33. Insulin Receptor Antibody-α-N-Acetylglucosaminidase Fusion Protein Penetrates the Primate Blood-Brain Barrier and Reduces Glycosoaminoglycans in Sanfilippo Type B Fibroblasts.
Boado RJ; Lu JZ; Hui EK; Lin H; Pardridge WM
Mol Pharm; 2016 Apr; 13(4):1385-92. PubMed ID: 26910785
[TBL] [Abstract][Full Text] [Related]
34. Eliminating Fc N-Linked Glycosylation and Its Impact on Dosing Consideration for a Transferrin Receptor Antibody-Erythropoietin Fusion Protein in Mice.
Yang J; Sun J; Castellanos DM; Pardridge WM; Sumbria RK
Mol Pharm; 2020 Aug; 17(8):2831-2839. PubMed ID: 32579360
[TBL] [Abstract][Full Text] [Related]
35. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
[TBL] [Abstract][Full Text] [Related]
36. Modulating the antibody density changes the uptake and transport at the blood-brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo.
Johnsen KB; Bak M; Melander F; Thomsen MS; Burkhart A; Kempen PJ; Andresen TL; Moos T
J Control Release; 2019 Feb; 295():237-249. PubMed ID: 30633947
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and brain uptake in the rhesus monkey of a fusion protein of arylsulfatase a and a monoclonal antibody against the human insulin receptor.
Boado RJ; Lu JZ; Hui EK; Sumbria RK; Pardridge WM
Biotechnol Bioeng; 2013 May; 110(5):1456-65. PubMed ID: 23192358
[TBL] [Abstract][Full Text] [Related]
38. Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate.
Pardridge WM; Kang YS; Buciak JL; Yang J
Pharm Res; 1995 Jun; 12(6):807-16. PubMed ID: 7667183
[TBL] [Abstract][Full Text] [Related]
39. Brain and Organ Uptake in the Rhesus Monkey in Vivo of Recombinant Iduronidase Compared to an Insulin Receptor Antibody-Iduronidase Fusion Protein.
Boado RJ; Pardridge WM
Mol Pharm; 2017 Apr; 14(4):1271-1277. PubMed ID: 28279069
[TBL] [Abstract][Full Text] [Related]
40. Enhanced anti-angiogenetic effect of transferrin receptor-mediated delivery of VEGF-trap in a glioblastoma mouse model.
Zhao P; Anami Y; Gao P; Fan X; Li L; Tsuchikama K; Zhang N; An Z
MAbs; 2022; 14(1):2057269. PubMed ID: 35388745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
